IntelliCare in College Students (ICCS)
14 de setembro de 2020 atualizado por: Emily G Lattie, Northwestern University
Expanding College Student Mental Health With Stress Management Mobile Technologies - Extended Usability Trial
This study is an 8-week usability and feasibility trial of the smartphone student stress-management app IntelliCare for college students.
This intervention will be tested with University of Illinois at Chicago (UIC) and Northern Illinois University (NIU) students.
During this period, research surveys assessing depression and anxiety can be completed on the app.
Also, user feedback interviews will be conducted viatelephone at four weeks and at eight weeks to gain insight on the user experience of IntelliCare for College Students.
Visão geral do estudo
Status
Concluído
Intervenção / Tratamento
Descrição detalhada
In this study, students will be recruited for an 8-week trial in which they will be given the IntelliCare Hub app and encouraged to use it daily.
To ensure a sample representative of likely end users, 10 students from each site will be recruited: 5 with elevated distress as measured by scores > 10 on either the PHQ-9 or GAD-7 and 5 without elevated scores on either measure, for a total of 20 participants.
The rationale for 10 participants in each group is based on past usability research indicating saturation is typically reached within 10 participants.
This trial aims to identify software bugs and usability problems that emerge over extended use and to examine preliminary effects of program use.
During the trial, participants will be prompted to complete the PHQ-8 and GAD-7 every week.
At baseline, 4 weeks, and 8 weeks, participants will be prompted within the app to complete the Depression Literacy Questionnaire and Anxiety Literacy Questionnaire to measure mental health literacy, the Knowledge and Beliefs about Services scale to measure knowledge of campus mental health services, the Barriers to Mental Health Help-Seeking questionnaire to measure treatment barriers, and the Cognitive and Behavioral Response to Stress Scale to measure cognitive and behavioral coping skills.
At 4 and 8 weeks participants will be asked to participate in a user-feedback interview via the telephone.
This is to gain insight on the user's experience with the app.
Tipo de estudo
Intervencional
Inscrição (Real)
20
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
Illinois
-
Chicago, Illinois, Estados Unidos, 60611
- Northwestern University
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
18 anos e mais velhos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Sim
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion Criteria:
Participant is a student at the University of Illinois in Chicago or Northern Illinois University. Participant owns a smartphone capable of running Android 7 (or higher) or iOS11 (or higher).
Participant is 18 years of age or older
Exclusion Criteria:
None
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Extended usability of a mobile self-help intervention
Participants will have open access to the Intellicare Hub app for 8-weeks and be surveyed at Baseline, 4-weeks, and 8-weeks
|
During the trial, participants will use Intellicare apps for up to 8 weeks and will be invited to provide feedback about their experience at two follow-up time points: weeks 4 and 8.
All participants will first undergo initial assessments that will include a series of online questionnaires about their mood.
Eligible participants will receive up to 8 weeks of access to the IntelliCare system, which consists of apps with a variety of resources, including lessons and tools designed to teach skills for mood management.
It is suggested that participants utilize the mobile phone tools every day
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Patient Health Questionnaire - 8 (PHQ-8) - Depression Severity Module
Prazo: Week 4
|
The PHQ-8 measures degree of depression severity. Possible range of scores for the PHQ-8 is 0-24. Higher values represent a worse outcome. Specifically, scores of 0-4 indicate minimal or no depression; 5-9 is mild; 10-14 is moderate; 15-19 is moderately severe; and 20-24 is severe. |
Week 4
|
|
Patient Health Questionnaire - 8 (PHQ-8) - Depression Severity Module
Prazo: Week 8
|
The PHQ-8 measures degree of depression severity. Possible range of scores for the PHQ-9 is 0-24. Higher values represent a worse outcome. Specifically, scores of 0-4 indicate minimal or no depression; 5-9 is mild; 10-14 is moderate; 15-19 is moderately severe; and 20-24 is severe. |
Week 8
|
|
GAD-7 (Generalized Anxiety Disorder Scale-7)
Prazo: Week 4
|
The GAD-7 is a self-administered 7 item instrument that uses some of the DSM-V criteria for GAD (General Anxiety Disorder) to identify probable cases of GAD along with measuring anxiety symptom severity.
GAD-7 total score for the seven items ranges from 0 to 21.
Higher values represent a worse outcome.
Specifically, scores of 1-4 indicate minimal anxiety symptoms; 5-9 is mild anxiety symptoms; 10-14 is moderate anxiety symptoms; and 15-21 is severe anxiety symptoms.
|
Week 4
|
|
GAD-7 (Generalized Anxiety Disorder Scale-7)
Prazo: Week 8
|
The GAD-7 is a self-administered 7 item instrument that uses some of the DSM-V criteria for GAD (General Anxiety Disorder) to identify probable cases of GAD along with measuring anxiety symptom severity.
GAD-7 total score for the seven items ranges from 0 to 21.
Higher values represent a worse outcome.
Specifically, scores of 1-4 indicate minimal anxiety symptoms; 5-9 is mild anxiety symptoms; 10-14 is moderate anxiety symptoms; and 15-21 is severe anxiety symptoms.
|
Week 8
|
|
Anxiety Literacy Questionnaire
Prazo: Week 4
|
This questionnaire is designed to assess anxiety specific mental health literacy by presenting 22 true or false statements regarding anxiety (e.g., "Being easily fatigued may be a symptom of anxiety disorder.")
Participants receive a score of 1 for each statement they correctly assign as either true or false.
Scores for each questionnaire can range from 0-22, with higher scores indicating greater anxiety specific mental health literacy.
|
Week 4
|
|
Anxiety Literacy Questionnaire
Prazo: Week 8
|
This questionnaire is designed to assess anxiety specific mental health literacy by presenting 22 true or false statements regarding anxiety (e.g., "Being easily fatigued may be a symptom of anxiety disorder.")
Participants receive a score of 1 for each statement they correctly assign as either true or false.
Scores for each questionnaire can range from 0-22, with higher scores indicating greater anxiety specific mental health literacy.
|
Week 8
|
|
Depression Literacy Questionnaire
Prazo: Week 4
|
This questionnaire is designed to assess depression specific mental health literacy by presenting 22 true or false statements regarding anxiety and depression (e.g., "Loss of confidence and poor self-esteem may be a symptom of depression.")
Participants receive a score of 1 for each statement they correctly assign as either true or false.
Scores for each questionnaire can range from 0-22, with higher scores indicating greater depression specific mental health literacy
|
Week 4
|
|
Depression Literacy Questionnaire
Prazo: Week 8
|
This questionnaire is designed to assess depression specific mental health literacy by presenting 22 true or false statements regarding anxiety and depression (e.g., "Loss of confidence and poor self-esteem may be a symptom of depression.")
Participants receive a score of 1 for each statement they correctly assign as either true or false.
Scores for each questionnaire can range from 0-22, with higher scores indicating greater depression specific mental health literacy
|
Week 8
|
|
Cognitive and Behavioral Response to Stress Scale
Prazo: Week 4
|
This is an 18-item scale designed to measure the use and helpfulness of various cognitive and behavioral skills.
There are four subscales included: cognitive skill frequency, cognitive skill usefulness, behavioral skill frequency, and behavioral skill usefulness.
For each cognitive or behavioral skill, participants rate how often they used the skill and how helpful it was (e.g.
"During the past month, how often did you take a moment to notice things that made you feel good or grateful?
How helpful was this in making you feel better?").
Scores for cognitive subscales range from 0-24, and scores from behavioral subscales can range from 0-30.
Higher scores indicate better outcomes.
|
Week 4
|
|
The Cognitive and Behavioral Response to Stress Scale
Prazo: Week 8
|
This is an 18-item scale designed to measure the use and helpfulness of various cognitive and behavioral skills.
There are four subscales included: cognitive skill frequency, cognitive skill usefulness, behavioral skill frequency, and behavioral skill usefulness.
For each cognitive or behavioral skill, participants rate how often they used the skill and how helpful it was (e.g.
"During the past month, how often did you take a moment to notice things that made you feel good or grateful?
How helpful was this in making you feel better?").
Scores for cognitive subscales range from 0-24, and scores from behavioral subscales can range from 0-30.
Higher scores indicate better outcomes.
|
Week 8
|
Medidas de resultados secundários
Medida de resultado |
Prazo |
|---|---|
|
Mean Number of Treatment App Use Sessions
Prazo: Daily for two months
|
Daily for two months
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Colaboradores
Publicações e links úteis
A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
8 de julho de 2019
Conclusão Primária (Real)
5 de novembro de 2019
Conclusão do estudo (Real)
5 de novembro de 2019
Datas de inscrição no estudo
Enviado pela primeira vez
23 de julho de 2019
Enviado pela primeira vez que atendeu aos critérios de CQ
25 de julho de 2019
Primeira postagem (Real)
29 de julho de 2019
Atualizações de registro de estudo
Última Atualização Postada (Real)
8 de outubro de 2020
Última atualização enviada que atendeu aos critérios de controle de qualidade
14 de setembro de 2020
Última verificação
1 de setembro de 2020
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- K08MH112878-EUT
- K08MH112878 (Concessão/Contrato do NIH dos EUA)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
INDECISO
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Mobile self-help intervention
-
University of NottinghamDesconhecidoSíndrome de Estresse do CuidadorReino Unido